Calgary, Canada

Sarah Serl

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Mind of Sarah Serl

Introduction

Sarah Serl, an accomplished inventor based in Calgary, Canada, has made significant contributions to the field of virology through her innovative research and development. With a total of four patents to her name, Sarah has focused her efforts on creating formulations that aim to enhance the stabilization and storage of viruses, an essential aspect of virological studies and medical applications.

Latest Patents

Among Sarah's most notable patents are her groundbreaking liquid viral formulations. These formulations provide a method for stabilizing and storing viruses, thereby preserving their infectivity and immunogenicity during storage periods. The formulations comprise a purified virus combined with a non-viral composition, including excipients and a liquid carrier. Additionally, her work on lyophilized viral formulations has furthered the field by offering an innovative approach to maintaining virus stability. These lyophilized formulations share a similar purpose, incorporating a purified virus and excipients, thereby ensuring that viruses remain viable for research and therapeutic applications.

Career Highlights

Sarah Serl is currently associated with Oncolytics Biotech Inc., a company dedicated to advancing cancer therapies and biotechnology solutions. Her innovative contributions are integral to the company's mission of improving treatment techniques for viral oncology. The advancements Sarah has made not only enhance the capabilities of her organization but also contribute significantly to the broader scientific community.

Collaborations

Throughout her career, Sarah has worked alongside distinguished professionals, including her colleagues Matthew C. Coffey and Leo Pavliv. These collaborations have fostered a productive environment that encourages the exchange of innovative ideas and the advancement of virology research.

Conclusion

In summary, Sarah Serl exemplifies the spirit of innovation in the realm of virology with her significant patents and collaborative efforts at Oncolytics Biotech Inc. Her work in developing liquid and lyophilized viral formulations demonstrates the critical intersection of science and invention, paving the way for advancements that benefit both research institutions and the medical community at large. As she continues to push the boundaries of innovation, Sarah remains a pivotal figure in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…